3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Ovarian Neoplasms
2
Breast Neoplasms
2
Anatomic Stage III Breast Cancer AJCC v8
2
Anatomic Stage I Breast Cancer AJCC v8
2
Wilms Tumor
1
Triple Negative Breast Neoplasms
1
Stage I Mixed Cell Type Kidney Wilms Tumor
1
Renal Insufficiency, Chronic
1
Prostatic Neoplasms
1
Pleuropulmonary blastoma
1
Pain
1
Neuroblastoma
1
Melanoma
1
Leukemia, Hairy Cell
1
Ganglioneuroblastoma
1
Carcinoma, Renal Cell
1
Carcinoma, Medullary
1
Carcinoma, Intraductal, Noninfiltrating
1
Anatomic Stage IV Breast Cancer AJCC v8
1
Interventions
selinexor
2
pembrolizumab
2
pazopanib
2
Nivolumab
2
Magnetic Resonance Spectroscopy
2
Ifosfamide
2
Doxorubicin
2
tazemetostat
1
metarrestin
1
fludarabine phosphate
1
fludarabine
1
Specimen Handling
1
Sirolimus
1
Radiotherapy
1
Radiation
1
Proton Therapy
1
Mesna
1
Ipilimumab
1
Cyclophosphamide
1
CTLA-4 Antigen
1
AZD 6244
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neurofibrosarcoma
×
High-Energy Shock Waves
×
90 days
×
Clear all
No trials found.